Large-scale testing (Phase 3)Ended earlyNCT01058759What this trial is testingTaxotere-Enoxaparin-(ENOXA)-StudyWho this might be right forNon-small Cell Lung Cancer Hannover Medical School 14
Testing effectiveness (Phase 2)Looking for participantsNCT07336732What this trial is testingAndamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR MutationsWho this might be right forNon-Small-Cell Lung Cancer Avistone Biotechnology Co., Ltd. 40
Large-scale testing (Phase 3)Ended earlyNCT00738387What this trial is testingASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Novartis Pharmaceuticals 900
Early research (Phase 1)Ended earlyNCT04287894What this trial is testingAssess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the TreatmentWho this might be right forStage III NSCLC The Netherlands Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00227708What this trial is testingDocetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forLung Cancer UNICANCER 58
Testing effectiveness (Phase 2)Ended earlyNCT03138889What this trial is testingBempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid TumorsWho this might be right forNon-Small Cell Lung Cancer Nektar Therapeutics 162
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06525350What this trial is testingEvaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung CancerWho this might be right forLocally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET Overexpression CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 256
Large-scale testing (Phase 3)Active Not RecruitingNCT06382116What this trial is testingA Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer(PANKU-Lung01)Who this might be right forNon-small Cell Lung Cancer Sichuan Baili Pharmaceutical Co., Ltd. 432
Testing effectiveness (Phase 2)Active Not RecruitingNCT05880706What this trial is testingBL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Sichuan Baili Pharmaceutical Co., Ltd. 198
Not applicableLooking for participantsNCT05559645What this trial is testingAssessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)Who this might be right forNon Small Cell Lung Cancer Peking Union Medical College Hospital 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06690671What this trial is testingA Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLCWho this might be right forLung Cancer, Non-Small Cell Shanghai Chest Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04846634What this trial is testingPenpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)Who this might be right forResectable Locally Advanced Non-small Cell Lung Cancer Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Ended earlyNCT00283634What this trial is testingTarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung CancerWho this might be right forNSCLC Millennium Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00754364What this trial is testingMono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly PatientsWho this might be right forNSCLC Armando Santoro, MD 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT03377023What this trial is testingPhase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung CancerWho this might be right forNon Small Cell Lung CancerLung Cancer, Nonsmall CellNon Small Cell Lung Cancer Metastatic H. Lee Moffitt Cancer Center and Research Institute 66
Testing effectiveness (Phase 2)Study completedNCT00832494What this trial is testingPhase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Antisoma Research 105
Large-scale testing (Phase 3)Study completedNCT00076388What this trial is testingIressa Versus Docetaxel (Taxotere)Who this might be right forNon-Small-Cell Lung Carcinoma AstraZeneca 1,440
Large-scale testing (Phase 3)Study completedNCT02125461What this trial is testingA Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer AstraZeneca 713
Not applicableNot Yet RecruitingNCT07418879What this trial is testingA Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLCWho this might be right forNon-small Cell Lung CancerRET FusionPralsetinib Fudan University 25
Post-approval studies (Phase 4)Study completedNCT00770588What this trial is testingAssess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer (NSCLC) AstraZeneca 296